Safety study of SSS67 in healthy adults
This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your weight must be at least 50 kg for men or 45 kg for women, and your BMI should be between 18.5 and 32.
- You need to be in good general health, with normal test results for your heart, lungs, blood, and other systems.
- You cannot have a history of serious allergies, heart rhythm problems, or cancer (except some skin cancers) in the last 5 years.
- You must agree to use effective birth control from screening until 6 months after the last dose, and not plan to donate sperm or eggs.
- You should not have taken any medications, supplements, or weight-loss products recently, or regularly do heavy weightlifting to build muscle.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This trial tests how a new medicine, SSS17, moves through and leaves the body in healthy Chinese men. It helps researchers understand how the drug works and if it is safe.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.